利福霉素钠，CAS 登记号 14897-39-3，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 利福霉素钠 的 CAS 号：14897-39-3，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
rifamycin sv sodium · CAS 14897-39-3 · C37H46NNaO12. UNII 32086GS35Z. European Pharmacopoeia monograph.
| CAS Registry Number | 14897-39-3 |
|---|---|
| PubChem CID | 23702994 |
| Molecular formula | C37H46NNaO12 |
| IUPAC name | sodium (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetyloxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-olate |
| UNII (FDA) | 32086GS35Z |
| Pharmacopoeial monograph | European Pharmacopoeia monograph |
| Molecular Weight | 719.7 |
|---|---|
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 3 |
| Exact Mass | 719.29177018 |
| Monoisotopic Mass | 719.29177018 |
| Topological Polar Surface Area | 204 |
| Heavy Atom Count | 51 |
| Formal Charge | 0 |
| Complexity | 1340 |
| GHS notification summary | 33.3% (1 / 3) |
|---|
| GHS notification summary | 33.3% (1 / 3) |
|---|---|
| Reported hazard statements | H315 (33.3%), H319 (66.7%), H335 (33.3%) |
This chemical does not meet GHS hazard criteria for 33.3% (1 of 3) of reports.
H315 (33.3%): Causes skin irritation [Warning Skin corrosion/irritation]
RIFAMYCIN SODIUM; Rifamycin SV sodium; 14897-39-3; Rifamastene; Rifamycinum natricum; 32086GS35Z; UNII-32086GS35Z; EINECS 238-965-7; CB-0111; CB-01-11; RIFAMYCIN SODIUM (MART.); RIFAMYCIN SODIUM [MART.]; RIFAMYCIN SODIUM (EP IMPURITY); RIFAMYCIN SODIUM [EP IMPURITY]; RIFAMYCIN SODIUM (EP MONOGRAPH); RIFAMYCIN SODIUM [EP MONOGRAPH]
CAS 14897-39-3; molecular formula C37H46NNaO12; molecular weight — g/mol.
RIFAMYCIN SODIUM, Rifamycin SV sodium, 14897-39-3, Rifamastene, Rifamycinum natricum, 32086GS35Z.
33.3% of GHS notifications report no hazard classification (1 of 3).
Yes — a monograph exists in the European Pharmacopoeia (Ph. Eur.).
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.